Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0294695 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Bonnie Bengtsson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Gastroenterology, Södersjukhuset, Stockholm, Sweden. Hauptthemen laut MEDLINE: Mucosal-Associated Invariant T Cells, Liver Cirrhosis, Biomarkers, Bacterial Infections. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Knut och Alice Wallenbergs Stiftelse, Cancerfonden, Novo Nordisk Fonden.
Abstract (Originalsprache)
Background and aims Infection is a serious complication in patients with cirrhosis. Mucosal-associated invariant T (MAIT) cells are involved in the immune defense against infections and known to be impaired in several chronic conditions, including cirrhosis. Here, we evaluated if MAIT cell levels in peripheral blood are associated with risk of bacterial infections in patients with cirrhosis.
Methods
Patients with cirrhosis seen at the Karolinska University Hospital, Stockholm, Sweden, between 2016 and 2019 were included. Levels of MAIT cells in peripheral blood were determined using flow cytometry. Baseline and follow-up data after at least two years of follow-up were collected by chart review for the primary outcome (bacterial infection) and secondary outcomes (decompensation and death). Competing risk and Cox regression were performed.
Results
We included 106 patients with cirrhosis. The median MAIT cells fraction in the circulation was 0.8% in cirrhosis compared to 6.1% in healthy controls. In contrast to our hypothesis, we found an association in the adjusted analysis between relatively preserved MAIT cell levels, and a slightly higher risk to develop bacterial infections (adjusted subdistribution hazard ratio (aSHR) 1.15 (95%CI = 1.01–1.31). However, MAIT cell levels were not associated with the risk of hepatic decompensation (aSHR 1.19 (95%CI = 0.91–1.56)) nor with death (adjusted hazard ratio 1.10 (95%CI = 0.97–1.22)).
Conclusions
Relatively preserved MAIT cell levels in blood of patients with cirrhosis were associated with a somewhat higher risk of bacterial infections. The clinical relevance of this might not be strong. MAIT cells might however be an interesting biomarker to explore in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Section of Gastroenterology, Södersjukhuset, Stockholm, Sweden.
- Unit of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Bonnie Bengtsson, Johan K Sandberg
Förderung
- Knut och Alice Wallenbergs Stiftelse
- Cancerfonden
- Novo Nordisk Fonden
- Vetenskapsrådet
- Center for Innovative Medicine
- Stiftelsen för Strategisk Forskning
- Radiumhemmets Forskningsfonder
- Karolinska Institutet
Zitieren
APA
Bengtsson, B., Maucourant, C., Sandberg, J. K., Björkström, N. K., & Hagström, H. (2024). Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0294695
Vancouver
Bengtsson B, Maucourant C, Sandberg JK, Björkström NK, Hagström H. Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis. PLOS ONE. 2024. doi:10.1371/journal.pone.0294695
BibTeX
@article{Bengtsson2024,
author = {Bengtsson, Bonnie and Maucourant, Christopher and Sandberg, Johan K and Björkström, Niklas K and Hagström, Hannes},
title = {Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0294695}
}
EUVIMED